Comprehensive medication reviews for elderly patients: Findings and recommendations to physicians

Journal of the American Pharmacists Association

Volumn 52, Issue 5, 2012, Pages 630-633

  Leikola, Saija N S ^a   Virolainen, Johanna ^a,b   Tuomainen, Lea ^c   Tuominen, Raimo K ^a   Airaksinen, Marja S A ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b PFIZER INC   (United States)

^c UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Community pharmacists; Comprehensive medication reviews; Drug therapy problems; Elderly; Medication safety

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIDEPRESSANT AGENT; ANTIULCER AGENT; ANXIOLYTIC AGENT; CALCIUM; CARDIOVASCULAR AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPNOTIC AGENT; IRON; MEPROBAMATE; NEUROLEPTIC AGENT; OPIATE; PARACETAMOL; SEDATIVE AGENT; WARFARIN;

ADULT; AGED; ARTICLE; COMPREHENSIVE MEDICATION REVIEW; DRUG CHOICE; DRUG INDICATION; FEMALE; FINLAND; GERIATRIC PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHARMACIST; PHYSICIAN; PRIMARY MEDICAL CARE; QUALITY CONTROL; RETROSPECTIVE STUDY; UNSPECIFIED SIDE EFFECT; ASSISTED LIVING FACILITY; DEMOGRAPHY; ORGANIZATION AND MANAGEMENT; PATIENT CARE PLANNING; PHARMACY; STATISTICS;

AGED; AGED, 80 AND OVER; ASSISTED LIVING FACILITIES; COMMUNITY PHARMACY SERVICES; FEMALE; HUMANS; MALE; PATIENT CARE PLANNING; RESIDENCE CHARACTERISTICS; RETROSPECTIVE STUDIES;

EID: 84874399630     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2012.10163     Document Type: Article

References (14)

1. Hilmer SN, McLachlan AJ, Le Couteur DG. Clinical pharmacology in the geriatric patient. Fundam Clin Pharmacol. 2007;21:217-30.
2. Sorensen L, Stokes JA, Purdie DM, et al. Medication reviews in the community: results of a randomized, controlled effectiveness trial. Br J Clin Pharmacol. 2004;58:648-64.
3. American Pharmacists Association, National Association of Chain Drug Stores Foundation. Medication therapy management in pharmacy practice: core elements of an MTM service model (version 2.0). J Am Pharm Assoc. 2008;48:341-53.
4. Laaksonen R, Duggan C, Bates I. Performance of community pharmacists in providing clinical medication reviews. Ann Pharmacother. 2010;44:1181-90.
5. Krska J, Cromarty JA, Arris F, et al. Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. Age Ageing. 2001;30:205-11.
6. Sellors J, Kazcorowski J, Sellors C, et al. A randomized controlled trial of pharmacist consultation program for family physicians and their elderly patients. CMAJ. 2003;169:17-22.
7. The Ministry of Social Affairs and Health, Finland. Safe pharmacotherapy among the aged: obligations for the municipalities [article in Finnish]. Accessed at www.stm.fi/tiedotteet/kuntainfot/kuntainfo/view/1236539, February 2, 2011.
8. Leikola SN, Tuomainen L, Ovaskainen H, et al. Continuing education course to attain collaborative comprehensive medication review competencies. Am J Pharm Educ. 2009;73(6):108.
9. Australian Government, Medicare Australia. Home medicines review (HMR). Accessed at www.medicareaustralia.gov.au/provider/pbs/fourth-agreement/hmr.jsp, April 20, 2011.
10. Pharmaceutical Care Network Europe Foundation. PCNE classification for drug-related problems V5.01. Accessed at www.pcne.org, May 27, 2009.
11. Doucette WR, McDonough RP, Klepser D, McCarthy R. Comprehensive medication therapy management: identifying and resolving drug-related issues in a community pharmacy. Clin Ther. 2005;27:1104-11.
12. Christensen DB, Roth M, Trygstad T, Byrd J. Evaluation of a pilot medication therapy management project within the North Carolina state health plan. J Am Pharm Assoc. 2007;47:471-83.
13. Rao D, Gilbert A, Strand LM, Cipolle RJ. Drug therapy problems found in ambulatory patient populations in Minnesota and South Australia. Pharm World Sci. 2007;29:647-54.
14. Bates DW. Role of pharmacists in the medical home. Am J Health Syst Pharm. 2009;66:1116-8.